Company
CBIO · CIK 0001253689
Sale of 3,839 shares at $16.71 per share.
Reporting Person McNeill Jonathan · Officer Title President and COO · Transaction Code S
Traded Sep 18, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001628280-26-062700 · filed 2026-09-18 · View filing →
Sale of 7,837 shares at $16.71 per share.
Reporting Person Brumm Joshua T · Officer Title Chief Executive Officer · Transaction Code S
Traded Sep 18, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001628280-26-062701 · filed 2026-09-18 · View filing →
Sale of 731 shares at $17.90 per share.
Reporting Person McNeill Jonathan · Officer Title President and COO · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001628280-26-062700 · filed 2026-09-18 · View filing →
Sale of 1,610 shares at $17.90 per share.
Reporting Person Brumm Joshua T · Officer Title Chief Executive Officer · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001628280-26-062701 · filed 2026-09-18 · View filing →
Sale of 620 shares at $17.90 per share.
Reporting Person Bispham Barbara Harlin · Officer Title See Remarks · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001628280-26-062703 · filed 2026-09-18 · View filing →
Sale of 568 shares at $17.90 per share.
Reporting Person Scalzo Richard William · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001628280-26-062705 · filed 2026-09-18 · View filing →
Sale of 623 shares at $17.90 per share.
Reporting Person Im Ellie Eunkyung · Officer Title Chief Medical Officer · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001628280-26-062706 · filed 2026-09-18 · View filing →
Sale of 658 shares at $17.90 per share.
Reporting Person Pinkas Jan · Officer Title Chief Scientific Officer · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001628280-26-062707 · filed 2026-09-18 · View filing →
Sale of 240 shares at $17.90 per share.
Reporting Person Lynch Ryan · Officer Title See Remarks · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001628280-26-062709 · filed 2026-09-18 · View filing →